AFM
CYT

Anson Funds Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Anson Funds Management’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,096,422
Closed -$3.33M – 226
2023
Q4 		$3.33M Sell
1,096,422
-227,692
-17% -$691K 0.41% 46
2023
Q3 		$3.76M Buy
1,324,114
+172,452
+15% +$475K 0.76% 29
2023
Q2 		$2.99M Buy
+1,151,662
New +$2.41M 0.5% 36

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Anson Funds Management's CYT Position: Q1 2024 in Review

Anson Funds Management sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 1,096,422 shares — an estimated $3.33M sold.

Anson Funds Management first reported a position in CYT in Q2 2023 and held it in 3 quarters. The position peaked at $3.76M in Q3 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • Anson Funds Management reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Anson Funds Management sold 1,096,422 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.33M.
  • Anson Funds Management first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Anson Funds Management's Cyteir Therapeutics, Inc. Common Stock position peaked at $3.76M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Anson Funds Management's 13F filing for Q1 2024, filed 14 May 2024.